These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15459764)

  • 1. The important role for betaVLDLs binding at the fourth cysteine of first ligand-binding domain in the low-density lipoprotein receptor.
    Iwasaki T; Takahashi S; Ishihara M; Takahashi M; Ikeda U; Shimada K; Fujino T; Yamamoto TT; Hattori H; Emi M
    J Hum Genet; 2004; 49(11):622-628. PubMed ID: 15459764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement of cysteine at position 46 in the first cysteine-rich repeat of the LDL receptor impairs apolipoprotein recognition.
    Benito-Vicente A; Uribe KB; Siddiqi H; Jebari S; Galicia-Garcia U; Larrea-Sebal A; Cenarro A; Stef M; Ostolaza H; Civeira F; Palacios L; Martin C
    PLoS One; 2018; 13(10):e0204771. PubMed ID: 30332439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity-associated effect of LDL receptor missense variants located in the cysteine-rich repeats.
    Etxebarria A; Benito-Vicente A; Stef M; Ostolaza H; Palacios L; Martin C
    Atherosclerosis; 2015 Feb; 238(2):304-12. PubMed ID: 25545329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
    Jong MC; van Dijk KW; Dahlmans VE; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker MH; Havekes LM
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein metabolism in familial hypercholesterolemia.
    Shepherd J; Packard CJ
    Arteriosclerosis; 1989; 9(1 Suppl):I39-42. PubMed ID: 2912431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia.
    Jones C; Garuti R; Michaely P; Li WP; Maeda N; Cohen JC; Herz J; Hobbs HH
    J Clin Invest; 2007 Jan; 117(1):165-74. PubMed ID: 17200716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.
    Boren J; Lee I; Zhu W; Arnold K; Taylor S; Innerarity TL
    J Clin Invest; 1998 Mar; 101(5):1084-93. PubMed ID: 9486979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity.
    Banerjee P; Chan KC; Tarabocchia M; Benito-Vicente A; Alves AC; Uribe KB; Bourbon M; Skiba PJ; Pordy R; Gipe DA; Gaudet D; Martin C
    Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2248-2260. PubMed ID: 31578082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular fate of LDL receptor family members depends on the cooperation between their ligand-binding and EGF domains.
    Van Hoof D; Rodenburg KW; Van der Horst DJ
    J Cell Sci; 2005 Mar; 118(Pt 6):1309-20. PubMed ID: 15741231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p.(Asp47Asn) and p.(Thr62Met): non deleterious LDL receptor missense variants functionally characterized in vitro.
    Benito-Vicente A; Siddiqi H; Uribe KB; Jebari S; Galicia-Garcia U; Larrea-Sebal A; Stef M; Ostolaza H; Palacios L; Martin C
    Sci Rep; 2018 Nov; 8(1):16614. PubMed ID: 30413722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia.
    Leitersdorf E; Hobbs HH; Fourie AM; Jacobs M; van der Westhuyzen DR; Coetzee GA
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):7912-6. PubMed ID: 3263645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of exon encoding cysteine-rich repeat of low density lipoprotein receptor alters its binding specificity in a subject with familial hypercholesterolemia.
    Hobbs HH; Brown MS; Goldstein JL; Russell DW
    J Biol Chem; 1986 Oct; 261(28):13114-20. PubMed ID: 3020025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LR11, a mosaic LDL receptor family member, mediates the uptake of ApoE-rich lipoproteins in vitro.
    Taira K; Bujo H; Hirayama S; Yamazaki H; Kanaki T; Takahashi K; Ishii I; Miida T; Schneider WJ; Saito Y
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1501-6. PubMed ID: 11557679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutation screening and functional analysis of low density lipoprotein receptor in a familial hypercholesterolemia family].
    Cheng XH; Zheng F; Zhou X; Xiong CL; Ding J; Chen YM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):55-8. PubMed ID: 18247305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FH Afrikaner-3 LDL receptor mutation results in defective LDL receptors and causes a mild form of familial hypercholesterolemia.
    Graadt van Roggen JF; van der Westhuyzen DR; Coetzee GA; Marais AD; Steyn K; Langenhoven E; Kotze MJ
    Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):765-72. PubMed ID: 7773731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compensated endocytosis of LDL by hamster cells co-expressing the two distinct mutant LDL receptors defective in endocytosis and ligand binding.
    Yoshida H; Yokode M; Yamamoto A; Masaki R; Murayama T; Horiuchi H; Kita T
    J Lipid Res; 1999 May; 40(5):814-23. PubMed ID: 10224150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor.
    Kobayashi K; Oka K; Forte T; Ishida B; Teng B; Ishimura-Oka K; Nakamuta M; Chan L
    J Biol Chem; 1996 Mar; 271(12):6852-60. PubMed ID: 8636110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor.
    Battey FD; Gåfvels ME; FitzGerald DJ; Argraves WS; Chappell DA; Strauss JF; Strickland DK
    J Biol Chem; 1994 Sep; 269(37):23268-73. PubMed ID: 8083232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of an exon 3 mutation (Trp66-->Gly) of the LDL receptor with variable expression of familial hypercholesterolemia in a French Canadian family.
    Levy E; Minnich A; Cacan SL; Thibault L; Giroux LM; Davignon J; Lambert M
    Biochem Mol Med; 1997 Feb; 60(1):59-69. PubMed ID: 9066982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.